Fuse Oncology Announces Strategic Collaboration with Radiation Oncology Leader
BOONE, N.C., Dec. 14, 2023 /PRNewswire/ -- Fuse Oncology (Fuse), a leading innovator in cutting-edge radiation oncology solutions, announced today a strategic collaboration with the University of Michigan , a recognized leader in radiation oncology.
- BOONE, N.C., Dec. 14, 2023 /PRNewswire/ -- Fuse Oncology (Fuse), a leading innovator in cutting-edge radiation oncology solutions, announced today a strategic collaboration with the University of Michigan , a recognized leader in radiation oncology.
- "Being an integral part of this transformative venture is truly inspiring," said Martha Matuszak, PhD, director of the physics division in U-M's Department of Radiation Oncology.
- Fuse's collaboration with U-M and Cone Health combines the expertise and resources of two radiation oncology powerhouses—sparking a new wave of innovation and product development.
- We are experiencing an exciting venture energy in the industry that makes this so rewarding," said Benjamin (BJ) Sintay, Executive Director of Radiation Oncology at Cone Health & Chief Innovation Officer at Fuse Oncology.